Novo Holdings participates in €23 million Series A for Tribune Therapeutics to advance next-generation anti-fibrotic therapies

DealMatrix gives you market-realistic EV/Sales and EV/EBITDA multiples for private companies, filtered by sector, stage and region, built on 20 years of data and IPEV-2025-compliant.